Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-14-005435
Filing Date
2014-11-10
Accepted
2014-11-10 17:10:53
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 dvax-8k_20141110.htm S-3 840034
2 EX-4.9 dvax-ex49_201411107.htm EX-4 410803
3 EX-5.1 dvax-ex51_2014111076.htm EX-5 46014
4 EX-12.1 dvax-ex121_2014111038.htm EX-12 162103
5 EX-23.1 dvax-ex231_2014111036.htm EX-23 2970
6 GRAPHIC g201411102153589511544.jpg GRAPHIC 30400
7 GRAPHIC g201411102154058961609.jpg GRAPHIC 13085
8 GRAPHIC g201411102154512871610.jpg GRAPHIC 15660
9 GRAPHIC g201411102155019431612.jpg GRAPHIC 15660
  Complete submission text file 0001564590-14-005435.txt   1566635
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-200083 | Film No.: 141209691
SIC: 2834 Pharmaceutical Preparations